Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q1 2023 Earnings

27FebConfirmed

Q2 2022

Q3 2022

Q4 2022

Q1 2023

-0.67

-0.5

-0.34

-0.17

Details

Expected EPS

-0.24

Actual EPS

-0.26

Surprise EPS

-0.02

Surprise Percent

+8.33%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.26 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.